社区劣势对美国与加拿大纤维性间质性肺病患者的影响
这项多中心前瞻性队列研究纳入美国和加拿大4,729例纤维性间质性肺病(fILD)患者,评估社区层面劣势与就诊严重程度、疾病进展、肺移植和死亡率的关联。结果显示,在美国队列中,最劣势社区患者死亡率最高(HR=1.51,P=0.002),特发性肺纤维化亚组肺移植几率最低(OR=0.46,P=0.04),而加拿大队列无此差异。
要点
- 美国fILD患者中,社区劣势最高四分位与死亡率增加相关(HR=1.51,P=0.002)。
- 美国特发性肺纤维化患者中,社区劣势最高四分位与肺移植几率降低相关(OR=0.46,P=0.04)。
- 两队列中社区劣势与基线DLCO降低相关,但与基线FVC或FVC/DLCO下降无关。
核心结论
- 美国fILD患者居住于社区劣势较高地区与死亡率增加相关。
- 美国特发性肺纤维化患者居住于社区劣势最高四分位地区与肺移植几率降低相关。
- 上述差异在加拿大患者中未观察到,可能反映两国就医可及性差异。
研究设计与样本
- 多中心、国际、前瞻性队列研究,纳入4,729例来自1个美国和一个加拿大ILD注册站点(共8个加拿大站点)的fILD患者。
- 社区层面劣势分别采用美国区域剥夺指数和加拿大多重剥夺指数测量。
主要发现
- 美国队列中,社区劣势最高四分位患者死亡风险最高(HR=1.51,P=0.002)。
- 美国特发性肺纤维化亚组中,社区劣势最高四分位患者肺移植几率最低(OR=0.46,P=0.04)。
- 两队列中,社区劣势较高均与基线DLCO降低相关。
- 两队列中,社区劣势与基线FVC或FVC、DLCO下降均无关。
临床怎么用
- 呼吸科医生应关注fILD患者所在社区的劣势程度,尤其在美国,可能提示死亡风险增加。
- 对特发性肺纤维化患者,需注意社区劣势较高者肺移植可及性可能降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Fibrotic interstitial lung disease (fILD) is a group of pathologic entities characterized by scarring of the lungs and high morbidity and mortality. Research investigating how socioeconomic and residential factors impact outcomes in patients with fILD is lacking. Objectives: To determine the association between neighborhood-level disadvantage and presentation severity, disease progression, lung transplantation, and mortality in patients with fILD from the United States and Canada. Methods: We performed a multicenter, international, prospective cohort study of 4,729 patients with fILD from one U.S. and eight Canadian ILD registry sites. Neighborhood-level disadvantage was measured by the area deprivation index in the United States and the Canadian Index of Multiple Deprivation in Canada. Measurements and Main Results: In the U.S. but not in the Canadian cohort, patients with fILD living in neighborhoods with the greatest disadvantage (top quartile) experience the highest risk of mortality (hazard ratio = 1.51, P = 0.002), and in subgroups of patients with idiopathic pulmonary fibrosis, the top quartile of disadvantage experienced the lowest odds of lung transplantation (odds ratio = 0.46, P = 0.04). Greater disadvantage was associated with reduced baseline DLCO in both cohorts, but it was not associated with baseline FVC or FVC or DLCO decline in either cohort. Conclusions: Patients with fILD who live in areas with greater neighborhood-level disadvantage in the United States experience higher mortality, and patients with idiopathic pulmonary fibrosis experience lower odds of lung transplantation. These disparities are not seen in Canadian patients, which may indicate differences in access to care between the United States and Canada.
引用
- Goobie GC, Ryerson CJ, Johannson KA, et al. Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease. Am J Respir Crit Care Med. 2022. PMID: 34818133. doi:10.1164/rccm.202109-2065OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。